Cantitate/Preț
Produs
Total produse
Vezi coșul
New Antibody Formats de Fernando Aranda Vega

New Antibody Formats: International Review of Cell and Molecular Biology, cartea 369

Fernando Aranda Vega, Pedro Berraondo, Lorenzo Galluzzi
en Limba Engleză Hardback – 19 iun 2022
New Antibody Formats, Volume 369 in the International Review of Cell and Molecular Biology serial, highlights new advances in the field with this new volume presenting interesting chapters on a variety of important topics, including Current innovative engineered antibodies, Advances in bispecific antibodies, Applications of trimerbodies for cancer immunotherapy, Multispecific mAb-Anticalin formats, New antibody formats to treat Lung Cancer, Immunocytokines: from bench to bedside, and Single domain antibodies in cancer.

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the International Review of Cell and Molecular Biology serials
  • Updated release includes the latest information on New Antibody Formats
Citește tot Restrânge

Din seria International Review of Cell and Molecular Biology

Preț: 94651 lei

Preț vechi: 133122 lei
-29% Nou

Puncte Express: 1420
Preț estimativ în valută:
18119€ • 19739$ • 15200£

Carte tipărită la comandă

Livrare economică 11-25 decembrie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323994026
ISBN-10: 0323994024
Pagini: 212
Dimensiuni: 152 x 229 x 18 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Seria International Review of Cell and Molecular Biology

Cuprins

. Current innovative engineered antibodies Jose Yelamos 2. Opportunities and challenges of bi-specific antibodies Aina Segués, Shuyu Huang, Alice Sijts, Pedro Berraondo and Dietmar M. Zaiss 3. Applications of trimerbodies in cancer immunotherapy Marta Compte, Laura Sanz and Luis Álvarez-Vallina 4. Anticalin®-based therapeutics: Expanding new frontiers in drug development Aizea Morales-Kastresana, Martin Siegemund, Stefan Haak, Janet Peper-Gabriel, Vanessa Neiens and Christine Rothe 5. Overcoming the limitations of cytokines to improve cancer therapy Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Myriam Fernandez-Sendin, Angela Bella, Fernando Aranda, Ignacio Melero and Pedro Berraondo 6. Emerging applications of nanobodies in cancer therapy Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W.M. De Groof, Yannick De Vlaeminck, Ahmet Krasniqi, Kim De Veirman, Cleo Goyvaerts, Matthias D’Huyvetter, Sophie Hernot, Nick Devoogdt and Karine Breckpot